Author:
Peters H.F.M,Bastiaanse R.,Van Borsel J.,Dejonckere P.H.O.,Jansonius-Schultheiss K.,Van der Meulen Sj.,Mondelaers B.J.E.
Reference35 articles.
1. Albert, M.L., Bachman, D., Morgan, A., & Helm-Estabrooks, N. (1988). Pharmacotherapy for aphasia. Neurology, 38, 877-879.
2. Bachman, D., & Morgan, A. (1988). The role of pharmacotherapy in the treatment of aphasia: preliminary results. Aphasiology, 2, 225-228.
3. Bergmann, P.S., & Green, M. (1951). Aphasia: effect of intravenous sodium amytal. Neurology, 1, 471-475.
4. Billow, B.W. (1949). Observation of the use of sodium amytal in the treatment of aphasia. Medical Record, 162, 12-13.
5. Bragoni, M., Altieri, M., Di Piero, V., Padovani, A., Mostardini, C., & Lenzi, G.I. (2000). Bromocriptine and speech therapie in non-fluent chronic aphasia after stroke. Neurological Sciences, 21, 19-22.